DUBLIN–(BUSINESS WIRE)–The “Global Biologics Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)” report has been added to ResearchAndMarkets.com’s offering.

The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2020-2024. The market is supported by various growth drivers such as rise in sedentary lifestyle, hike in spending on healthcare, increasing biologics approval, growing incidence of chronic conditions among the aging population, increased availability of advanced diagnostics, rising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases and advancement in healthcare & biotechnology.

Yet the market faces some restraints which are obstructing the growth of the market. Some of the major challenges faced by the industry are emergence of biosimilars, high cost of biologics, lack of oral absorption and operational challenges. Ongoing Covid-19 pandemic is posing challenges for the market as far as the year 2020 is concerned.

This report provides an in-depth analysis of the global biologics market with detailed analysis of the market in terms of value and segments. The report includes a brief regional analysis of North America, South America, Europe, Asia Pacific and Middle East & Africa with their actual and forecasted market size. Under competitive landscape, key competitors in the market have been compared on the basis of share.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2020-2024 , taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Company Coverage

(Read more…)

• Abbvie Inc
• Samsung Electronics (Samsung Biologics)
• F.Hoffmann La Roche
• Amgen Inc.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Global Market Analysis

3.1 Global Pharmaceuticals Market Analysis

3.1.1 Global Pharmaceuticals Market by Value

3.1.2 Global Pharmaceuticals Market by Segments (Non Biologics and Biologics)

3.2 Global Biologics Market Analysis

3.2.1 Global Biologics Market by Value

3.2.2 Global Biologics Manufacturing Market by Value

3.2.3 Global Biologics Manufacturing Market by Segments

3.2.4 Global Bio CMO Market by Value

3.2.5 Global Biologics In-House Market by Value

3.3 Global Biologics Market Product Analysis

3.3.1 Global Biologics Market by Product-Category

3.3.2 Global Biologics Monoclonal Antibodies Market by Value

3.3.3 Global Biologics Recombinant Protein Market by Value

3.3.4 Global Biologics Vaccines Market by Value

3.3.5 Global Biologics Regenerative Medicines Market by Value

3.4 Global Biologics Market Therapeutic Area Analysis

3.4.1 Global Biologics Market by Therapeutic Areas

3.4.2 Global Inflammatory Diseases Biologics Market by Value

3.4.3 Global Oncology and Immunomodulatory Biologics Market by Value

3.4.4 Global Anti-Infectives Biologics Market by Value

3.5 Global Biologics Market Regional Analysis

3.5.1 Global Biologics Market by Region

4. Regional Analysis

4.1 North America Biologics Market Analysis

4.1.1 North America Biologics Market by Value

4.2 South America Biologics Market Analysis

4.2.1 South America Biologics Market by Value

4.3 Europe Biologics Market Analysis

4.3.1 Europe Biologics Market by Value

4.4 Asia Pacific Biologics Market Analysis

4.4.1 Asia Pacific Biologics Market by Value

4.5 Middle East and Africa Biologics Market Analysis

4.5.1 Middle East and Africa Biologics Market by Value

5. Impact of Covid-19

5.1 Impact on Global Bio CMO Market

5.1.1 CMO Market and Covid-19

5.1.2 Participation of CDMOs in Covid-19 Vaccine Development Projects

5.1.3 CDMOs Planning for Fill and Finish Manufacture of Covid-19 Vaccine

6. Market Dynamics

6.1 Growth Drivers

6.1.1 Rise in Sedentary Lifestyle

6.1.2 Hike in Spending on Healthcare

6.1.3 Elevation in Biologics Approvals

6.1.4 Rising Autoimmune Disease Prevalence

6.1.5 Preference of Biologics Over Small Molecules

6.2 Challenges

6.2.1 Growing Number of Biosimilars

6.2.2 Lack of Oral Absorption

6.2.3 Operational and Technological Challenges

6.2.4 High Cost

6.3 Market Trends

6.3.1 Research and Development Activities (R&D) Activities

6.3.2 Spike in Mergers and Acquisitions (M&A) Activity

6.3.3 Demand of Biologics in the Treatment of Complex Diseases

6.3.4 Biologics for the Treating of Dermatological Conditions

6.3.5 Advancement in Healthcare and Biotechnology

6.3.6 Commercial Success of Biotech Products

6.3.7 Reimbursement Policy

7. Competitive Landscape

7.1 Global Biologics Market Players Analysis

7.1.1 Global Biologics Market by Top Selling Drugs

7.1.2 China Biologics Market Players by Share

8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/mjkhxq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

DUBLIN–(BUSINESS WIRE)–The “Global Biologics Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)” report has been added to ResearchAndMarkets.com’s offering.

The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2020-2024. The market is supported by various growth drivers such as rise in sedentary lifestyle, hike in spending on healthcare, increasing biologics approval, growing incidence of chronic conditions among the aging population, increased availability of advanced diagnostics, rising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases and advancement in healthcare & biotechnology.

Yet the market faces some restraints which are obstructing the growth of the market. Some of the major challenges faced by the industry are emergence of biosimilars, high cost of biologics, lack of oral absorption and operational challenges. Ongoing Covid-19 pandemic is posing challenges for the market as far as the year 2020 is concerned.

This report provides an in-depth analysis of the global biologics market with detailed analysis of the market in terms of value and segments. The report includes a brief regional analysis of North America, South America, Europe, Asia Pacific and Middle East & Africa with their actual and forecasted market size. Under competitive landscape, key competitors in the market have been compared on the basis of share.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2020-2024 , taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Company Coverage

(Read more…)

• Abbvie Inc
• Samsung Electronics (Samsung Biologics)
• F.Hoffmann La Roche
• Amgen Inc.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Global Market Analysis

3.1 Global Pharmaceuticals Market Analysis

3.1.1 Global Pharmaceuticals Market by Value

3.1.2 Global Pharmaceuticals Market by Segments (Non Biologics and Biologics)

3.2 Global Biologics Market Analysis

3.2.1 Global Biologics Market by Value

3.2.2 Global Biologics Manufacturing Market by Value

3.2.3 Global Biologics Manufacturing Market by Segments

3.2.4 Global Bio CMO Market by Value

3.2.5 Global Biologics In-House Market by Value

3.3 Global Biologics Market Product Analysis

3.3.1 Global Biologics Market by Product-Category

3.3.2 Global Biologics Monoclonal Antibodies Market by Value

3.3.3 Global Biologics Recombinant Protein Market by Value

3.3.4 Global Biologics Vaccines Market by Value

3.3.5 Global Biologics Regenerative Medicines Market by Value

3.4 Global Biologics Market Therapeutic Area Analysis

3.4.1 Global Biologics Market by Therapeutic Areas

3.4.2 Global Inflammatory Diseases Biologics Market by Value

3.4.3 Global Oncology and Immunomodulatory Biologics Market by Value

3.4.4 Global Anti-Infectives Biologics Market by Value

3.5 Global Biologics Market Regional Analysis

3.5.1 Global Biologics Market by Region

4. Regional Analysis

4.1 North America Biologics Market Analysis

4.1.1 North America Biologics Market by Value

4.2 South America Biologics Market Analysis

4.2.1 South America Biologics Market by Value

4.3 Europe Biologics Market Analysis

4.3.1 Europe Biologics Market by Value

4.4 Asia Pacific Biologics Market Analysis

4.4.1 Asia Pacific Biologics Market by Value

4.5 Middle East and Africa Biologics Market Analysis

4.5.1 Middle East and Africa Biologics Market by Value

5. Impact of Covid-19

5.1 Impact on Global Bio CMO Market

5.1.1 CMO Market and Covid-19

5.1.2 Participation of CDMOs in Covid-19 Vaccine Development Projects

5.1.3 CDMOs Planning for Fill and Finish Manufacture of Covid-19 Vaccine

6. Market Dynamics

6.1 Growth Drivers

6.1.1 Rise in Sedentary Lifestyle

6.1.2 Hike in Spending on Healthcare

6.1.3 Elevation in Biologics Approvals

6.1.4 Rising Autoimmune Disease Prevalence

6.1.5 Preference of Biologics Over Small Molecules

6.2 Challenges

6.2.1 Growing Number of Biosimilars

6.2.2 Lack of Oral Absorption

6.2.3 Operational and Technological Challenges

6.2.4 High Cost

6.3 Market Trends

6.3.1 Research and Development Activities (R&D) Activities

6.3.2 Spike in Mergers and Acquisitions (M&A) Activity

6.3.3 Demand of Biologics in the Treatment of Complex Diseases

6.3.4 Biologics for the Treating of Dermatological Conditions

6.3.5 Advancement in Healthcare and Biotechnology

6.3.6 Commercial Success of Biotech Products

6.3.7 Reimbursement Policy

7. Competitive Landscape

7.1 Global Biologics Market Players Analysis

7.1.1 Global Biologics Market by Top Selling Drugs

7.1.2 China Biologics Market Players by Share

8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/mjkhxq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900